You have 9 free searches left this month | for more free features.

Condition

COVID-19 (1)

Covid19 (1)

Endothelial Dysfunction (1)

Idiopathic Pulmonary Fibrosis (1)

Study Vasodilatory Effects of C21 (1)

Type2diabetes (1)

Overall Status

Completed (3)

Recruiting (2)

Sign in for free

Phase

phase 1 (2)

phase 2 (2)

phase 3 (1)

Sponsor

Vicore Pharma AB (5)

Collaborator

Orphan Reach (2)

CTC Clinical Trial Consultants AB (1)

Intervention

c21 (5)

placebo (2)

sodium nitroprusside (1)

Study Documents

Intervention Type

drug (5)

Funder Type

Industry (5)

Study Type

Interventional (5)

c21

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Study Vasodilatory Effects of C21 Trial in Uppsala (C21, Sodium Nitroprusside)

Completed

Study Vasodilatory Effects of C21

C21
Sodium Nitroprusside

Uppsala, Uppsala Lân, Sweden

Clinical Trial Consultants AB

Nov 11, 2022

Type2diabetes, Endothelial Dysfunction Trial in Malmö (C21)

Recruiting

Type2diabetes
Endothelial Dysfunction

C21

Malmö, Sweden

Skånes universitetssjukhus

Apr 25, 2023

Idiopathic Pulmonary Fibrosis Trial in Worldwide (C21)

Recruiting

Idiopathic Pulmonary Fibrosis

C21

Ahmedabad, Gujarat, India
+23 more

Jan 2, 2023

COVID-19 Trial in India, United Kingdom (C21, Placebo)

Completed

COVID-19

C21
Placebo

Ahmadabad, Gujarat, India
+8 more

Jun 21, 2021

Covid19 Trial in Worldwide (C21, Placebo)

Completed

Covid19

C21
Placebo

Orange, California
+60 more

Sep 8, 2022